You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2026

AbstractFullPdf
Jun 202027527574
Jul 202017817868
Aug 2020848456
Sep 202010510555
Oct 202012112146
Nov 2020687056
Dec 2020818141
Jan 202110210274
Feb 2021747441
Mar 202110210248
Apr 2021828238
May 2021787840
Jun 202111511548
Jul 202111811851
Aug 202110510579
Sep 202111111171
Oct 2021999975
Nov 202110210278
Dec 2021868862
Jan 2022919668
Feb 2022858858
Mar 202211812377
Apr 202212013266
May 202210510660
Jun 2022919251
Jul 2022919558
Aug 2022888968
Sep 2022110116282
Oct 20229710073
Nov 202212012470
Dec 2022898955
Jan 2023929239
Feb 202312813052
Mar 2023858940
Apr 2023838358
May 2023929255
Jun 2023778033
Jul 2023888949
Aug 202310510656
Sep 202317317638
Oct 202331231233
Nov 202351651659
Dec 2023747429
Jan 2024747533
Feb 2024686831
Mar 2024798069
Apr 2024879037
May 2024525842
Jun 2024656534
Jul 20246870150
Aug 2024495225
Sep 2024727259
Oct 2024808146
Nov 2024959654
Dec 2024798147
Jan 2025808049
Feb 202513913977
Mar 202511011251
Apr 202510310351
May 2025535433
Jun 2025494917
Jul 2025220
Oct 2025110
Mar 2026110
Total652266083533